PLCH2 and rheumatoid arthritis: In conclusion, the C2 domain-containing protein PLCη2 was downregulated in RA FLSs, and augmenting PLCη2 or its C2 domain attenuated the inflammatory and aggressive traits of RA FLSs, thus hindering RA progression.